{"version":"1.0","width":620,"height":178,"type":"rich","provider_name":"LISTEN","provider_url":"https:\/\/listen.style","url":"https:\/\/listen.style\/p\/lpvjjt7w\/8cn07m9e\/player","title":"\u30103\/2 2\u6642\u3011TechCrunch SaaSpocalypse VC\u6295\u8cc7\u5bb6\u306e\u5909\u5316\u30fbGenerate Biomedicines $400M IPO","author_name":"Koy","author_url":"https:\/\/listen.style\/p\/lpvjjt7w","html":"<iframe src=\"https:\/\/listen.style\/p\/lpvjjt7w\/8cn07m9e\/player\" title=\"\u30103\/2 2\u6642\u3011TechCrunch SaaSpocalypse VC\u6295\u8cc7\u5bb6\u306e\u5909\u5316\u30fbGenerate Biomedicines $400M IPO\" scrolling=\"no\" frameborder=\"0\" style=\"width: 100%; height: 178px;\"><a href=\"https:\/\/listen.style\/p\/lpvjjt7w\/8cn07m9e\/player\">\u30103\/2 2\u6642\u3011TechCrunch SaaSpocalypse VC\u6295\u8cc7\u5bb6\u306e\u5909\u5316\u30fbGenerate Biomedicines $400M IPO<\/a><\/iframe>"}